Proceedings Paper
Optical surgical navigation for nodal staging: to see or not to see?| Format | Member Price | Non-Member Price |
|---|---|---|
| $17.00 | $21.00 |
Paper Abstract
The success of optical surgical navigation depends upon being able to intraoperatively employ a contrast agent and an imaging device to successfully guide surgery. Development of devices and contrast agents typically occur separately even though it is their combined performance that ultimately determines success and clinical adoption. Herein, we review critical issues and summarize our strategies and approaches for validating molecularly-targeted, near-infrared fluorescent contrast agents and the devices sufficiently sensitive enough for their detection in order to guide lymph node dissection.
Paper Details
Date Published: 4 March 2016
PDF: 7 pages
Proc. SPIE 9696, Molecular-Guided Surgery: Molecules, Devices, and Applications II, 96960G (4 March 2016); doi: 10.1117/12.2224851
Published in SPIE Proceedings Vol. 9696:
Molecular-Guided Surgery: Molecules, Devices, and Applications II
Brian W. Pogue; Sylvain Gioux, Editor(s)
PDF: 7 pages
Proc. SPIE 9696, Molecular-Guided Surgery: Molecules, Devices, and Applications II, 96960G (4 March 2016); doi: 10.1117/12.2224851
Show Author Affiliations
Eva M. Sevick-Muraca, The Univ. of Texas Health Science Ctr. at Houston (United States)
Barrett R. Harvey, The Univ. of Texas Health Science Ctr. at Houston (United States)
Barrett R. Harvey, The Univ. of Texas Health Science Ctr. at Houston (United States)
John C. Rasmussen, The Univ. of Texas Health Science Ctr. at Houston (United States)
Banghe Zhu, The Univ. of Texas Health Science Ctr. at Houston (United States)
Banghe Zhu, The Univ. of Texas Health Science Ctr. at Houston (United States)
Published in SPIE Proceedings Vol. 9696:
Molecular-Guided Surgery: Molecules, Devices, and Applications II
Brian W. Pogue; Sylvain Gioux, Editor(s)
© SPIE. Terms of Use
